Patent issues pinch Glenmark again, outcome may take 2 yrs - CNBC-TV18 -

Drug firm Glenmark appears to have landed up in some trouble over a cholesterol drug it launched called Tarka, reports CNBC-TV18's Ekta Batra. Glenmark had launched Tarka generic at risk in June 2010 in the US markets. After that there was a litigation which was going on with the patent with the innovator Abbott, at the same time as when Glenmark had launched it at risk.